Skip to main content

Table 1 Essential inputs for the model

From: Cost-effectiveness of screening mammography in a low income country: a Markov simulation analysis

Name

Live value

 

Distribution

Reference

Age distribution of Breast cancer

  

Beta

Kantelhardt, et al. [14]

 30–39

 

0.000853

  

 40–49

 

0.000878

  

 50–59

 

0.00079

  

 60–69

 

0.000656

  

Stage progression transition probabilities

Stage I

Age 40–49

Age 50–59

Beta

Gocgun et al. [15]

 Remission to local recurrence

0.01

0.009

  

 Remission to distal recurrence

0.000016

0.000025

  

 Local recurrence to distal recurrence

0.062

0.052

  

 Local recurrence to cancer death

0.013

   

 Distal recurrence to cancer death

0.555

0.137

  

Stage II & III

  

Beta

 

 Remission to local recurrence

0.018

0.016

  

 Remission to distal recurrence

0.024

0.105

  

 Local recurrence to distal recurrence

0.165

0.13

  

 Distal recurrence to cancer death

0.386

0.423

  

Stage IV

  

Beta

 

 Distal recurrence to cancer death

0.386

0.423

  

Mammography sensitivity and specificity (40–49, 50–59 years)

 

Beta

Keen et al. [16]

 Sensitivity

 

0.821, 0.921

  

 Specificity

 

0.859, 0.859

  

Breast cancer stage distribution, screened

 

MBT

Wong et al. [17]

 Stage I

 

0.521

  

 Stage II

 

0.382

  

 Stage III

 

0.057

  

 Stage IV

 

0.041

  

Breast cancer stage distribution, Non-screened

 

MBT

Tesfaw et al. [18]

 Stage I

 

0.1

  

 Stage II

 

0.189

  

 Stage III

 

0.569

  

 Stage IV

 

0.143

  

FNAC(USD)

 

22

Invariant

Personal communication

Cost of mammography(USD)

 

Invariant

Personal communication

Government Institutions

 

4.5

  

Private institutions

 

42

  

Doctor visit cost

 

6

  

Treatment cost(USD)

  

Gamma

 

 Stage I

 

160

 

Hoang Lan, et al. [19]

 Stage II

 

458.48

  

 Stage III

 

850.45

  

 Stage IV

 

668.7

  

Expected life, 40–44

36.10367697

Gamma

World Health Organization [19]

Expected life, 45–49

31.72113989

Gamma

World Health Organization [19]

  1. FNAC fine-needle aspiration cytology, MBT multivariate beta distribution, USD United States Dollars